Title of article :
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
Author/Authors :
Bengt I Eriksson، نويسنده , , Ola E Dahl، نويسنده , , Nadia Rosencher، نويسنده , , Andreas A Kurth، نويسنده , , C. Niek van Dijk، نويسنده , , Simon P. Frostick، نويسنده , , Martin H. Prins، نويسنده , , Rohan Hettiarachchi، نويسنده , , Stefan Hantel، نويسنده , , Janet Schnee، نويسنده , , Harry R. Büller، نويسنده ,
Abstract :
Background
After hip replacement surgery, prophylaxis following discharge from hospital is recommended to reduce the risk of venous thromboembolism. Our aim was to assess the oral, direct thrombin inhibitor dabigatran etexilate for such prophylaxis.
Metho
